81 - Culturally Competent Community Engagement Strategies: Social Determinants of Health

Friday, October 1, 2021

11:30 AM - 12:45 PM EDT

Moderator(s)

TT

Tina Tan, MD

Professor of Pediatrics, Feinberg School of Medicine of Northwestern University, Infectious Diseases Attending, Lurie Children's Hospital of Chicago
Feinberg School of Medicine, Northwestern University
Chicago, IL, United States

GSK (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; ILiAD (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; Moderna (Individual(s) Involved: Self): Advisor or Review Panel member; Pfizer (Individual(s) Involved: Self): Advisor or Review Panel member

Speaker(s)

Kristen Feemster, MD MPH MSHP

Adjunct Associate Professor of Pediatrics, Infectious Diseases
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, United States

Merck & Co., Inc (Individual(s) Involved: Self): Employee
Damani Piggott, MD, PhD

Associate Professor of Medicine and Epidemiology & Associate Vice Provost for Graduate Diversity and Partnerships
Johns Hopkins University, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Celia Maxwell, MD, FACP, FIDSA

Associate Dean for Research
Howard University College of Medicine
Washington, DC, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rachel Civen, MD;MPH

Medical Director
Community Health Services Los Angeles County Department of Public Health
Glendale, CA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Tina Q. Tan, MD: GSK (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; ILiAD (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; Moderna (Individual(s) Involved: Self): Advisor or Review Panel member; Pfizer (Individual(s) Involved: Self): Advisor or Review Panel member

Kristen Feemster, MD MPH MSHP: Merck & Co., Inc (Individual(s) Involved: Self): Employee

Damani Piggott, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Celia J. Maxwell, MD, FACP, FIDSA: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rachel H. Civen, MD;MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the historical origins of the systemic inequalities in healthcare
recognize how social determinants are measured and the role they play in community engagement
explain the science behind the development of strategies for interventions to most effectively reach a community and how to assess the impact of the interventions

Presentations:

Assessing the Impact of Interventions
Speaker: Kristen Feemster, MD MPH MSHP – University of Pennsylvania Perelman School of Medicine
Historical Context of Systemic Inequities in Health through the Lens of COVID-19
Speaker: Damani Piggott, MD, PhD – Johns Hopkins University
Understanding Social Determinants Vis-a-vis Engagement
Speaker: Celia J. Maxwell, MD, FACP, FIDSA – Howard University College of Medicine
Vaccine Equity Strategies: Closing the Gaps for COVID-19 Vaccination, Los Angeles County Department of Public Health
Speaker: Rachel H. Civen, MD;MPH – Community Health Services Los Angeles County Department of Public Health